The DNASE1L3 gene helps clear away loose DNA from dying cells, especially in blood and other body fluids. This gene helps your body avoid reacting to that debris as if it were a threat. If it does not work well, extra DNA can build up and may trigger immune problems, including rare forms of lupus and blood vessel inflammation. Many variants in the DNASE1L3 gene have little or no effect.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which are the parts of cells that do the work. Others mainly guide when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also shape how you respond to food, stress, or medicines. For a closer look at this topic, you can find more in the LearnHub.
Overview
DNASE1L3Gene function
What if the gene works
The DNASE1L3 gene helps make an enzyme that cuts up extra DNA released from dying cells. This cleanup supports normal immune balance and lowers the chance that stray DNA will trigger inflammation.
Risk
What if the gene does not work
More disruptive variants in the DNASE1L3 gene can cause early-onset lupus or vasculitis, often affecting the kidneys, skin, or blood vessels. Milder variants may leave some enzyme activity and can be linked to later onset or fewer features.
Treatment
What does that mean for your treatment
No treatment or drug selection strategy based on the DNASE1L3 gene is currently established in clinical guidelines. Research is exploring reduced DNASE1L3 activity as a biomarker in lupus and vasculitis, and experimental enzyme replacement approaches are under study.
Conditions associated with DNASE1L3
Gene function
What if the gene works
In everyday cell cleanup, the DNASE1L3 gene helps clear loose DNA that appears outside cells. Its protein works mainly in blood and other body fluids, where it cuts DNA from dying cells into smaller pieces. This is an important part of clearing DNA from dying cells in the bloodstream and keeping normal immune balance.
The DNASE1L3 gene makes an enzyme that cuts apart DNA released from worn out or dying cells. This helps your body remove genetic material that no longer belongs outside cells.
Its protein is released into the blood, where it breaks down free DNA and DNA attached to tiny cell fragments. This supports routine cleanup in places where cell debris can collect.
DNASE1L3 is especially good at digesting DNA that stays wrapped around cell proteins after a cell dies. That matters because this packed DNA can be harder for other cleanup enzymes to reach.
By helping remove stray DNA, the DNASE1L3 gene supports the immune system’s ability to treat normal cell debris as waste to be cleared. This helps the body maintain a calmer, more controlled response during everyday tissue turnover.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Some variants in the DNASE1L3 gene change the enzyme’s shape, stability, or release from cells, which helps explain how DNASE1L3 gene variants affect function. Milder variants may leave some DNA-cutting activity, while more severe variants can sharply reduce activity or stop the protein from being made at all. When this happens, DNA fragments can linger outside cells and are more likely to trigger immune signaling.
How variants are linked to conditions
Pathogenic variants in the DNASE1L3 gene can cause a rare inherited form of systemic lupus erythematosus and are also linked to hypocomplementemic urticarial vasculitis syndrome, an autoimmune condition that may include hives, blood vessel inflammation, and kidney problems. In broader population studies, some variants in the DNASE1L3 gene linked to lupus appear to raise the chance of autoimmune disease, but these risk-related findings do not mean a person will definitely develop symptoms.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of being human and are widely seen across the population. Most do not directly affect health and instead reflect natural differences between people. For many genes, having a variant connected with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DNASE1L3, risk is mainly shaped by the gene change itself, especially when someone inherits nonworking copies linked to lupus-like autoimmune illness. There is not enough evidence to say that lifestyle changes clearly lower this genetic risk. What can still help is early monitoring for symptoms and prompt care if signs of inflammation appear.
Inheritance of DNASE1L3 variants
For families asking how DNASE1L3 gene variants are inherited, the best-established pattern is autosomal recessive. This means a person usually inherits one altered copy of the DNASE1L3 gene from each parent, and parents who each carry one variant are often healthy themselves. When both parents are carriers, each pregnancy has a 25% chance of a child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Because the DNASE1L3 gene is on chromosome 3, it is inherited equally by children of any sex.
What does my DNASE1L3 result mean for my family?
For families with a disease-causing change in the DNASE1L3 gene, the pattern is usually recessive, which means brothers and sisters could also be affected or could be carriers even if they feel well. Parents are often carriers, and other close relatives may be carriers too. Children of someone with DNASE1L3-related illness are usually carriers unless the other parent also carries a disease-causing change in the same gene.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the DNASE1L3 gene usually uses a blood or saliva sample. In DNASE1L3 genetic testing, a lab reads the gene’s DNA code to look for changes and reports whether a variant was found, which can help clarify whether this gene is involved in a person’s condition.
When should I consider getting a genetic test?
Testing for the DNASE1L3 gene may be worth discussing if lupus or blood-vessel inflammation starts very early in life, is unusually severe, or runs in your family. It can also help explain a child or young adult’s symptoms when standard testing has not given a clear answer.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they reveal varies based on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, so the same treatment may work better for some people than for others. These differences are common and can influence how much benefit a medicine provides or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the DNASE1L3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or your health are best discussed with your doctor.
History
The DNASE1L3 gene entered medical research in the late 1990s, when scientists identified a related DNA cutting enzyme that was distinct from the better known DNASE1 family member. Initially understood only through visible traits, later recognized as tied to a specific gene, it became more important as studies connected rare inherited variants to lupus like autoimmune illness. From these first observations, research expanded steadily. By the 2010s, DNASE1L3 had been linked to childhood onset systemic lupus erythematosus and related inflammatory vessel conditions, helping explain why some families showed unusually early or severe disease. More recent work has placed the DNASE1L3 gene in the broader story of how the immune system clears DNA debris and how failures in that process may contribute to autoimmunity.